Navigation Links
Stanmore Receives US FDA Approval for its JTS Non-invasive Extendible Implant
Date:6/24/2011

LONDON, June 24, 2011 /PRNewswire/ --


 

Stanmore Implants ("Stanmore"), specialists in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, announces that it has received US FDA 510k approval for its Juvenile Tumour System ("JTS") non-invasive extendible distal femoral replacement ("JTS implant"), for use in paediatric orthopaedic oncology surgery.  

The JTS implant is used to replace large sections of the distal femur (thigh bone) that has been removed during surgery, often to treat cancer. Previously patients had to undergo multiple, painful surgeries in order to lengthen their implants as they grew. The JTS implant uses an electromagnetic device in order to lengthen the prosthesis without the need for surgery, anaesthesia or sedation, thus reducing the risk of complications.

In November 2002 the first patient, a 13-year-old girl received the JTS non-invasive extendible implant in the UK. Today she has reached skeletal maturity with legs of equal length. Since then over 240 devices have been implanted at specialist centres in 15 countries worldwide. Each implant is designed and manufactured specifically for the recipient patient by the team at Stanmore.

The JTS implant also has significant health economic benefits. A recent US study identified that it costs US$267 to undertake a non-invasive lengthening procedure compared to approximately US$8,000 if surgery is required. Lengthening procedures are undertaken regularly and can be undertaken in doctors' surgeries or outpatient departments.

Brian Steer, Executive Chairman of Stanmore, said:

"Gaining approval in the key US market is a major achievement for Stanmore. Having used the product for nine years in the European markets we are absolutely confident of the product's ability to significantly improve patient outcomes and quality of life by negating the need for repeated surgery in children. This has very
'/>"/>

SOURCE Stanmore Implants
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  Essentialis announced ... Foundation for Prader-Willi Research (FPWR) to support clinical ... safety and efficacy of diazoxide choline controlled release ... study is being conducted at the University of ... Virginia Kimonis . "We have found ...
(Date:7/23/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... , announced today that it has been selected by the ... be a supplier of the seasonal influenza vaccine to the ... The Beijing CDC plans to order a minimum of ... from four domestic vaccine manufacturers for its vaccination campaign. Each ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Emulsifiers - Global Strategic Business Report" ... http://photos.prnewswire.com/prnh/20130307/600769 This report ... Tons and US$ Thousands by the following Product ... Sucroglycerides, Polysorbates and Sorbitan Esters, and Polyglycin Polyricinoleate ...
Breaking Medicine Technology:Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 3
... LAKE FOREST, Ill., Feb. 14, 2011 Hospira, Inc. (NYSE: ... delivery company, today announced that the company will present at ... Institutional Investors Conference March 8, 2011 ... Barclays Capital 2011 Global Healthcare Conference ...
... Calif., Feb. 14, 2011 / PRNewswire/ -- ... a $22 million Series D financing round led by ... were Split Rock Partners, Legacy Life Sciences, EDF Ventures, ... Asset Management Partners.  In connection with the financing, Dr. ...
Cached Medicine Technology:Sonoma Orthopedic Products® Closes $22 Million Series D Financing 2
(Date:7/23/2014)... 23, 2014 QueenBeeTickets.com is reducing the prices ... coup for rock music fans who are still in the ... visit the site, they can use promo code “DISCOUNT” to ... to view the inventory of discounted tickets at QueenBeeTickets.com. ... August, September and October, with The Eagles concert tickets literally ...
(Date:7/23/2014)... July 23, 2014 Temecula Valley ... Temecula Valley Southern California Wine Country artisan food ... and two nights genuinely nourishing. Savor like locals ... Palumbo, and Vindemia wineries; EAT Marketplace, Palumbo’s Ristorante, ... Temecula Olive Oil,” announced Kimberly Adams, president and ...
(Date:7/23/2014)... 2014 In an effort to help ... Alzheimer’s Disease” at the state level, the National ... Foundation of America (AFA) this week released a ... crisis, and the need for wide-scale implementation of state ... , The white paper outlines recommendations for ...
(Date:7/23/2014)... four in five older Americans living with multiple chronic ... Hopkins Bloomberg School of Public Health finds that the ... your life expectancy. The analysis, one of the first ... life expectancy among the elderly, may help explain why ... , A report on the findings, based on an ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses and ... of white party dresses to its product category. ... now available on its website. As a special offer, all ... can get a discounted rate, up to 54% off. , ... customers, so its marketing specialist believes the new white party ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... Inc. (Amex:,ULU) announced today that Ronald A. Ahrens has ... Mr. Ahrens has been an advisor to Merck ... of Merck Consumer Healthcare Group Worldwide.,He had previously served ... From 1985 to 1990 Mr. Ahrens was Consumer,Group President, ...
... 23 The American Society of,Transplantation (AST) recently ... Award, to Richard N. Fine, M.D. at the,American ... a,senior investigator whose lifelong work has advanced the ... the field and the,AST have been broad and ...
... clot-busting tPA, researchers say , , MONDAY, June 23 (HealthDay ... boost stroke patients, survival, new research suggests. , Gleevec, ... as chronic myelogenous leukemia (CML), will be tested to ... the side effects of the clot-dissolving drug tissue plasminogen ...
... and Public Health Experts to Raise Public ... Awareness Via Mobile Media, ... HIV testing is getting out to the general public, thanks to,the ... most reliable wireless voice and data network,announced today its continued effort ...
... 23 Boston Scientific,Corporation (NYSE: BSX ) today ... will help service veterans and the active armed forces,better ... has recently,passed the Veterans Mental Health Improvements Act, which ... originally introduced,by Senator Daniel Akaka (D-HI). The bill calls ...
... Therapeutic Vaccines for Infectious ... Diseases, ... on emerging understanding of the human immune system,today announced the closing of ... Partners, The Column Group and Versant,Ventures. The Column Group initially incubated the ...
Cached Medicine News:Health News:ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors 2Health News:AST Awards Richard N. Fine, M.D. 2008 Ernest Hodge Distinguished Achievement Award 2Health News:Cancer Drug Gleevec Could Fight Stroke 2Health News:Cancer Drug Gleevec Could Fight Stroke 3Health News:Verizon Wireless Continues Support of National HIV Testing Awareness Campaign 2Health News:Verizon Wireless Continues Support of National HIV Testing Awareness Campaign 3Health News:Boston Scientific Welcomes Progress on Pain Care Legislation 2Health News:Boston Scientific Welcomes Progress on Pain Care Legislation 3Health News:Boston Scientific Welcomes Progress on Pain Care Legislation 4Health News:Immune Design Announces $18 Million Series A Financing 2Health News:Immune Design Announces $18 Million Series A Financing 3
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
Medicine Products: